Delivery Order SPE2DE21D0005-SPE2D625F7F8A
Award Date 5/12/25
Potential Completion Date 5/15/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency's Medical Supply Chain division on September 23, 2025. The contract, which operates under a fixed-price arrangement with economic price adjustment provisions, is for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The delivery order is scheduled for completion by September 26, 2025, and was awarded...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 for APLIGRAF on May 30, 2025, with an ultimate completion date of June 4, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. APLIGRAF is an advanced wound care and tissue regeneration product that falls within Organogenesis's core portfolio...
- This $1,239.95 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Medical Supply Chain division of the Defense Logistics Agency. The order is for APLIGRAF, a wound care product, and has a completion date of March 20, 2024. Organogenesis previously held several large Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and Defense Logistics Agency to supply surgical implants, wound care matrices, and other tissue...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F228P) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the delivery of the advanced wound care product APLIGRAF. The order is a Fixed Price with Economic Price Adjustment contract with a completion date of November 1, 2024. Organogenesis, headquartered in Canton, Massachusetts, is a key supplier of medical products to federal...
- This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The order is for $1,239.95 in APLIGRAF wound care products, with a completion date of March 29, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) that Organogenesis holds with the DLA for wound care dressings, discs, and other medical materials. Organogenesis has also...
- Organogenesis Inc., a Canton, Massachusetts-based regenerative medicine company, received a delivery order award valued at $1,239.95 from the Defense Logistics Agency's Medical Supply Chain for APLIGRAF, an advanced wound care and tissue regeneration product. The contract, awarded on May 7, 2025, carries a fixed price structure with economic price adjustment provisions and is scheduled for completion by May 12, 2025. No set-aside designation was used in this award, indicating Organogenesis...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The $1,239.95 fixed-price order is for the advanced wound care product APLIGRAF. This delivery order is part of a larger $49.5 million Indefinite Delivery Contract (IDC) the DLA has with Organogenesis for a variety of wound care dressings and medical supplies, which runs from June 2021 to June 2026. Organogenesis also...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Organogenesis Inc., a for-profit manufacturer of advanced regenerative medicine products. The $1,239.95 fixed-price contract is for the supply of the APLIGRAF wound care product, with a period of performance through November 1, 2024. Organogenesis is an established federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of...
- This is a fixed-price federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, with a ceiling value of $1,239.95 and a period of performance through June 27, 2025. Organogenesis is an established federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans...
- This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....